
Sunday, September 25, 2022 9:33:36 PM
https://ih.advfn.com/stock-market/NASDAQ/immatics-nv-IMTX/stock-news/88273266/immatics-announces-first-quarter-2022-financial-re
Here is what caught my attention:
"The next data read-out for the IMA203 monotherapy cohort is planned for 2H 2022."
Hope the results are better than the IMA202 program which was terminated.
The dive on the chart sort of says results could be poor,however it has dropped on lighterish volume. We are well into 2H of 2022.

Liked By
Spread the love. Be the first to like this post!
Recent IMTX News
- Annual and Transition Report (foreign Private Issuer) (20-f) • Edgar (US Regulatory) • 03/22/2023 10:57:22 AM
- Immatics Announces Full Year 2022 Financial Results and Corporate Update • GlobeNewswire Inc. • 03/21/2023 11:31:38 AM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 03/13/2023 10:31:17 AM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/14/2023 10:24:03 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/14/2023 09:02:47 PM
- Schedule 13g<br /> (sc 13g) • Edgar (US Regulatory) • 02/07/2023 11:07:40 AM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 01/09/2023 12:07:26 PM
- SVB Securities Sticks to Their Buy Rating for Immatics (IMTX) • TipRanks • 11/21/2022 04:15:41 AM
- Chardan Capital Sticks to Their Buy Rating for Immatics (IMTX) • TipRanks • 11/17/2022 11:15:19 PM
- Immatics Announces Third Quarter 2022 Financial Results and Business Update • GlobeNewswire Inc. • 11/17/2022 12:00:00 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 11/10/2022 02:12:01 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 10/18/2022 12:07:11 PM
- Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) • Edgar (US Regulatory) • 10/11/2022 10:31:44 AM
- Immatics Rises on $110M Underwritten Offering • TipRanks • 10/10/2022 01:28:02 PM
- Immatics Announces $110 Million Underwritten Offering of Ordinary Shares • GlobeNewswire Inc. • 10/10/2022 11:37:42 AM
- Immatics Reports Interim Clinical Data Update on ACTengine® IMA203 TCR-T Monotherapy Targeting PRAME • GlobeNewswire Inc. • 10/10/2022 11:36:02 AM
- SVB Securities Remains a Buy on Immatics (IMTX) • TipRanks • 09/14/2022 03:45:55 AM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 09/12/2022 11:01:18 AM
- Analysts Offer Insights on Healthcare Companies: Immatics (IMTX), Biogen (BIIB) and Bicycle Therapeutics (BCYC) • TipRanks • 09/11/2022 06:20:19 AM
- Immatics Presents Comprehensive Preclinical Data Set for TCR Bispecific Candidate IMA402 Targeting PRAME at European Society for Medical Oncology (ESMO) Congress 2022 • GlobeNewswire Inc. • 09/10/2022 07:06:16 AM
- SVB Securities Sticks to Its Buy Rating for Immatics (IMTX) • TipRanks • 09/07/2022 04:05:18 AM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 08/23/2022 11:13:27 AM
- Immatics Announces First Cancer Patient Treated with Second-Generation ACTengine® TCR-T Candidate IMA203CD8 Targeting PRAME • GlobeNewswire Inc. • 08/23/2022 11:00:00 AM
- SVB Securities Keeps Their Buy Rating on Immatics (IMTX) • TipRanks • 08/11/2022 03:16:13 AM
- Chardan Capital Remains a Buy on Immatics (IMTX) • TipRanks • 08/09/2022 10:35:12 PM
Metatron Releases All-in-One Artificial Intelligence Mobile Apps for iPhone and Android • MRNJ • Mar 27, 2023 9:00 AM
Memorandum of Understanding With Miranda Water Treatment Systems and Rainmaker Worldwide Inc. Extended • RAKR • Mar 27, 2023 8:50 AM
Hollywall Entertainment Inc., (OTC:HWAL) Announces the completion of its 2021 and 2020 Audit (s) • HWAL • Mar 24, 2023 12:48 PM
Glucose Health, Inc. Fiscal 2022 Annual Report • GLUC • Mar 23, 2023 3:23 PM
Nextech3D.ai Announces Its AI-Powered SaaS Platform Toggle3D Experiences A +963% Jump in Users in 60-Days Crossing Over 1000 Users • NTAR • Mar 23, 2023 7:07 AM
Lifecycle Assessment by Benchmark Shows TMC's NORI-D Nodule Project Could Outperform Land-Based Routes of Producing Nickel, Copper and Cobalt in Almost Every Impact Category Analyzed • TMC • Mar 22, 2023 1:44 PM